Clinical Trial Update: Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated how food affects the safety, tolerability, and pharmacokinetics of EC-18 administered orally in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• EC-18

Snippet

Sponsor: Enzychem Lifesciences Corporation | Conditions: Chemotherapy-Induced Neutropenia | Phase 1 | Status: COMPLETED